References
For reviews, see:
1a
Cole DC.
Tetrahedron
1994,
50:
9517
1b
Juaristi E.
Quintana D.
Escalante J.
Aldrichimica Acta
1994,
27:
3
1c
Enantioselective Synthesis of b-Amino Acids
Juaristi E.
Wiley-VCH;
New York:
1997.
1d
Juaristi E.
Lopez-Ruiz H.
Current Medical Chemistry
1999,
6:
983
2 For example, see: Kim S.
Lee PH.
Lee TA.
J. Chem. Soc., Chem. Commun.
1988,
1242
3 For example, see: Jefford CW.
Wang JB.
Tetrahedron Lett.
1993,
34:
2911
4 For example, see: Jefford CW.
Wang JB.
Tetrahedron Lett.
1993,
34:
3119
5 For a review on β-peptides, see: Gellman SH.
Acc. Chem. Res.
1998,
31:
173
6
Leonard F.
Wajngurt A.
Klein M.
Smith CM.
J. Org. Chem.
1961,
26:
4062
7
Arvanitis E.
Ernst H.
Ludwig AL.
Robinson AJ.
Wyatt PB.
J. Chem. Soc. Perkin Trans. 1
1998,
521
8
Jiang N.
Qu Z.
Wang J.
Org. Lett.
2001,
3:
2989
9
General procedure for the TsOH catalyzed diazo decomposition: To a solution of TsOH (1 mg) in anhydrous CH2 Cl2 (20 mL) at 0 °C under N2 , was added dropwise a solution of diazo compound in anhydrous CH2 Cl2 (5 mL). The reaction was complete within 30 min as indicated by TLC check. Solvent was removed by evaporation, and the residue was purified by flash column chromatography to give cis and trans α-aryl-β-enamino esters as a mixture.
10
Cimarelli C.
Palmieri G.
J. Org. Chem.
1996,
61:
5557
11
General procedure for the hydrogenation of a-aryl-b-enamino esters: To a solution of α-aryl-β-enamino esters (50 mg, cis and trans mixture) in absolute MeOH (25 mL) was added 10% Pd/C catalyst (10 mg). The reaction mixture was stirred for 10 h under 1 atm hydrogen atmosphere. Then catalyst was removed by filtration and solvent was evaporated to give a residue, which was purified by flash column chromatography.
3a : 1 H NMR (200 MHz, CDCl3 ): δ 1.13 (t, 3 H), 2.36 (s, 3 H), 3.19-352 (m, 2 H), 3.79-3.86 (q, 1 H), 4.04-4.17 (m, 2 H), 5.13 (t, 1 H), 7.13 (m, 7 H), 7.72 (d, 2 H); 13 C NMR (50 MHz, CDCl3 ): δ 13.88, 21.42, 45.62, 51.72, 61.27, 126.91, 127.82, 127.84, 128.88, 129.68, 135.63, 136.86, 143.40, 172.34; MS m/z (relative intensity): 347 (M+ , 17%), 118 (100%).
3b : 1 H NMR (200 MHz, CDCl3 ) δ 1.18 (t, 3H), 2.42 (s, 3 H), 3.16-3.50 (m, 2H), 3.77-3.81 (m, 1 H), 3.79 (s, 3H), 4.04-4.17 (m, 2 H), 5.07 (t, 1 H), 6.83 (d, 2 H), 7.06 (d, 2 H), 7.29 (d, 2 H), 7.72 (d, 2 H); 13 C NMR (50 MHz, CDCl3 ): δ 13.90, 21.41, 45.67, 50.82, 55.14, 61.18, 114.25, 126.91, 127.60, 128.90, 129.65, 136.90, 143.36, 159.14, 172.56; MS m/z (relative intensity): 377 (M+ , 10%), 194 (100%).
3c : 1 H NMR (200 MHz, CDCl3 ) δ 1.19 (t, 3 H), 2.39 (s, 3 H), 3.21-3.55 (m, 2 H), 3.84-3.91(q, 1 H), 4.04-4.20 (m, 2 H), 5.07 (t, 1 H), 7.20-7.57 (m, 1 1H), 7.71 (d, 2 H); 13 C NMR (50 MHz, CDCl3 ): δ 13.96, 21.45, 45.65, 51.40, 61.39, 126.95, 127.45, 127.60, 128.30, 129.71, 134.60, 136.89, 140.26, 140.82, 143.45, 172.36. m/z (relative intensity): 423 (M+ , 11%), 240 (100%).
3d : 1 H NMR (200 MHz, CDCl3 ) δ 1.17 (t, 3 H), 2.42 (s, 3 H), 3.15-3.50 (m, 2 H), 3.78-3.85 (q, 1 H), 4.04-4.18 (m, 2 H), 5.20 (t, 1 H), 6.92-7.30 (m, 6 H), 7.70 (d, 2 H); 13 C NMR (50 MHz, CDCl3 ): δ 13.87, 21.41, 45.57, 50.92, 61.37, 115.55, 115.98, 126.89, 129.44, 129.60, 129.69, 136.79, 143.47, 172.19. m/z (relative intensity): 365 (M+ , 24%), 182 (100%).
3e : 1 H NMR (200 MHz, CDCl3 ) δ 1.18 (t, 3 H), 2.42 (s, 3 H), 3.20-3.55 (m, 2 H), 3.87-3.94 (q, 1 H), 4.04-4.17 (m, 2 H), 5.13 (t, 1 H), 7.29 (m, 2 H), 7.31-7.56 (m, 4 H), 7.70 (m, 2 H); 13 C NMR (50 MHz, CDCl3 ): δ 13.84, 21.42, 45.44, 51.55, 61.61, 124.74, 124.81, 126.91, 129.42, 131.44, 136.68, 136.78, 143.62, 171.70. m/z (relative intensity): 415 (M+ , 8%) 184 (100%).
3f : 1 H NMR (200 MHz, CDCl3 ) δ 1.22 (t, 3 H), 1.97 (m, 2 H), 2.39 (s, 3 H), 2.83 (t, 2 H), 3.89 (d, 2 H), 4.02-4.20 (m, 4 H), 5.15 (t, 1 H), 7.23 (d, 2 H), 7.68 (d, 2 H); 13 C NMR (50 MHz, CDCl3 ): δ 14.32, 21.40, 23.74, 31.15, 39.35, 59.84, 72.16, 76.36, 76.99, 77.63, 98.03, 127.10, 129.11, 137.59, 142.79, 167.55, 173.76. m/z (relative intensity): 339 (M+ , 14%), 184 (100%).
12 For the α-aryl-β-enamino esters 5f and 6f , the hydrogenation gave a product with the furanyl moiety being partially hydrogenated. The structure of the 3f (Figure) is as follows.
Figure